A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

Clinical trial NCT07071090 · RECRUITING

Trial details

NCT number: NCT07071090
Sponsor: Heronova Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancies

Start date: 2025-06-30
Primary completion: 2028-01-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.